Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -66.60% is in line with its 5-year average of -61.09%, around the middle of its 5-year range (-176.65%–8.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.22% above its 12-month average of -66.74%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -66.60%.
RETURN ON INVESTED CAPITAL (ROIC)
-66.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-66.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-64.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-61.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.22%
CURRENT VS 3Y AVG
-3.34%
CURRENT VS 5Y AVG
-9.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
-110.61%
vs the sector median at left
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.01B
Return on Invested Capital (ROIC)
-66.60%
TTM Avg
-66.74%
3Y Avg
-64.44%
5Y Avg
-61.09%
Market Cap
$3.04B
Return on Invested Capital (ROIC)
9.95%
TTM Avg
-25.98%
3Y Avg
-51.77%
5Y Avg
-51.95%
Market Cap
$3.09B
Return on Invested Capital (ROIC)
-13.88%
TTM Avg
-29.89%
3Y Avg
-36.62%
5Y Avg
-30.08%
Market Cap
$3.05B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-45.69%
3Y Avg
-35.19%
5Y Avg
-27.59%
Market Cap
$2.80B
Return on Invested Capital (ROIC)
-58.28%
TTM Avg
-46.81%
3Y Avg
-91.88%
5Y Avg
-70.41%
Market Cap
$2.83B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$2.81B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
-4.01%
3Y Avg
-5.25%
5Y Avg
-2.96%
Market Cap
$2.74B
Return on Invested Capital (ROIC)
-28.60%
TTM Avg
-26.51%
3Y Avg
-39.35%
5Y Avg
-39.35%
Market Cap
$2.71B
Return on Invested Capital (ROIC)
15.45%
TTM Avg
14.86%
3Y Avg
6.92%
5Y Avg
-8.67%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.01B | -66.60% | -66.74% | -64.44% | -61.09% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.04B | 9.95% | -25.98% | -51.77% | -51.95% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.09B | -13.88% | -29.89% | -36.62% | -30.08% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.05B | -50.82% | -45.69% | -35.19% | -27.59% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.80B | -58.28% | -46.81% | -91.88% | -70.41% |
| TransMedics Group, Inc. (TMDX)vs › | $2.83B | 5.87% | 7.96% | -0.22% | -9.17% |
| AtriCure, Inc. (ATRC)vs › | $2.81B | 2.04% | -4.01% | -5.25% | -2.96% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.74B | -28.60% | -26.51% | -39.35% | -39.35% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.71B | 15.45% | 14.86% | 6.92% | -8.67% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | 6.69% | 7.54% | 8.48% | 6.84% |
ROIC
-66.6%
ROE
-63.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -66.60% |
| 2026-03-31 | -57.37% |
| 2025-12-31 | -49.46% |
| 2025-09-30 | -46.56% |
| 2025-06-30 | -113.74% |
| 2025-03-31 | -102.88% |
| 2024-12-31 | -176.65% |
| 2024-09-30 | -126.67% |
| 2024-06-30 | -59.11% |
| 2024-03-31 | -24.94% |
| 2023-12-31 | 8.09% |
| 2023-09-30 | -1.01% |
| 2023-06-30 | -20.83% |
| 2023-03-31 | -43.66% |
| 2022-12-31 | -58.39% |
| 2022-09-30 | -124.37% |
| 2022-06-30 | -77.39% |
| 2022-03-31 | -47.68% |
| 2021-12-31 | -93.73% |
| 2021-09-30 | -54.48% |
